Bases Neurobiológicas y Psicológicas de los Trastornos Mentales. Trastornos del Neurodesarrollo

Kosik-Gonzalez, C; Fu, DJ; Chen, LN; Lane, R; Bloch, MH; Delbello, M; Moreno, C; Drevets, WC; Canuso, CM.

Effect of Esketamine on Depressive Symptoms in Adolescents With Major Depressive Disorder at Imminent Suicide Risk: A Randomized Psychoactive-Controlled Study

JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY. 2026; 65(1): 42-55 Nº de citas: 5 [doi:10.1016/j.jaac.2025.02.015]

Braak, S; Oldehinkel, M; Mennes, M; Su, TJ; Pijnenburg, Y; Arango, C; Ayuso-Mateos, JL; van der Wee, N; Dawson, GR; Marston, HM; Beckmann, CF; Kas, MJH; Penninx, BWJH.

Default mode network integrity across neuropsychiatric disorders and its relation to social dysfunction: A normative modelling approach

EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2026; 102: 28-38 Nº de citas: 2 [doi:10.1016/j.euroneuro.2025.11.002]

Rodriguez-Cabo, B; Catalan, A; Aymerich, C; Pablo, GSD; Gonzalez-Torres, MA.

Unveiling the prognosis of adult Catatonia: A systematic review

SCHIZOPHRENIA RESEARCH. 2026; 287: 21-36 [doi:10.1016/j.schres.2025.11.006]

Vieta, E; Montejo, AL; Pillinger, T; Dell'Osso, BM; Dimitraka, M; Farooq, S; Jesus, G; Torres, CP; Wobrock, T; Pappa, S.

Managing schizophrenia with affective, sexual, metabolic and substance-use comorbidities: pharmacological considerations from an expert consensus

ANNALS OF GENERAL PSYCHIATRY. 2025; 25(1): [doi:10.1186/s12991-025-00620-7]

Garriz-Luis, A; Rodríguez-Toscano, E; Burdeus-Olavarrieta, M; Arango, C; Parellada, M; Díaz-Caneja, CM.

Clinical and neuropsychological characterization of Jacobsen syndrome (del11q)

JOURNAL OF NEURODEVELOPMENTAL DISORDERS. 2025; 18(1): [doi:10.1186/s11689-025-09659-9]

Demjaha, A; Stahl, D; Arango, C; Glenthoj, B; Rodriguez-Jimenez, R; Díaz-Caneja, CM; Baandrup, L; Ebdrup, B; Garcia-Portlla, MP; Diaz-Marsa, M; Winter-van Rossum, I; Kahn, R; Dazzan, P; McGuire, P.

Confirmatory factor analysis of competing PANSS negative symptom models: data from OPTiMiSE first-episode schizophrenia study

BJPsych Open. 2025; 12(1): Nº de citas: 1 [doi:10.1192/bjo.2025.10922]

Latrèche C; Mancini V; Dvojakovska M; Kushan L; Mchangama F; Tair F; Cohen T; Spapens J; Reijn L; Díaz-Caneja CM; Acheampong H; Troch L; Vergaelen E; Vogels A; Swillen A; Vingerhoets C; Boot E; Arango C; Velders F; Fiksinski A; van Amelsvoort T; Gothelf D; Bearden CE; Chaumette B; Schneider M; Eliez S.

Multicenter retrospective study on effectiveness, reported side effects, and cognitive outcomes of SSRIs in 22q11.2 deletion syndrome.

Research Square. 2025; : [doi:10.21203/rs.3.rs-8286229/v1]

Gosling, CJ; Garcia-Argibay, M; De Prisco, M; Arrondo, G; Ayrolles, A; Antoun, S; Caparos, S; Catalán, A; Ellul, P; Dobrosavljevic, M; Farhat, LC; Fico, G; Eudave, L; Groenman, AP; Hojlund, M; Jurek, L; Nourredine, M; Oliva, V; Parlatini, V; Psyllou, C; Salazar-de-Pablo, G; Tomlinson, A; Westwood, SJ; Cipriani, A; Correll, CU; Yon, DK; Larsson, H; Ostinelli, EG; Il Shin, J; Fusar-Poli, P; Ioannidis, JPA; Radua, J; Solmi, M; Delorme, R; Cortese, S.

Benefits and harms of ADHD interventions: umbrella review and platform for shared decision making

BMJ-British Medical Journal. 2025; 391: Nº de citas: 3 [doi:10.1136/bmj-2025-085875]

Echave, MM; Schnack, HG; Díaz-Caneja, CM; Pina-Camacho, L; Janssen, N; Gordaliza, PM; Kho, KH; Buimer, EEL; Van Haren, NEM; Cahn, W; Kahn, RS; Pol, HEH; Arango, C; Janssen, J.

Individualized cortical thickness asymmetry in autism spectrum disorder and schizophrenia

MOLECULAR PSYCHIATRY. 2025; : [doi:10.1038/s41380-025-03359-5]

De Giorgi, R; Lomax, T; Moreno, C; Van Assche, E; Osimo, EF; Bajorek, T; Sen, A; Fazel, S; Baune, BT; Kandasamy, R; Yu, RQ; Peña-Ceballos, J; Lattanzi, S; Camazon, PA; Del Rincon, CR; Yogarajah, M; Assenza, G; Robinson, T; Aledo-Serrano, A; Cipriani, A.

Epilepsy and mental health disorders: current challenges and potential solutions

BRITISH JOURNAL OF PSYCHIATRY. 2025; : [doi:10.1192/bjp.2025.10455]

Oquendo, MA; Barrigon, ML; Baca-Garcia, E.

Psychiatry at the turn of the century and a vision for future developments

INTERNATIONAL REVIEW OF PSYCHIATRY. 2025; : [doi:10.1080/09540261.2025.2591200]

Lopez-Morinigo, JD; Fraguas, D; Diaz-Caneja, CM; Galvañ, J; Berger, G; Leucht, S; Rossum, IWV; Arango, C; Moreno, C.

Depressive symptomatology in the first-episode schizophrenia spectrum disorders OPTiMiSE trial: prevalence, correlates, symptom progression and outcomes

Schizophrenia. 2025; 11(1): [doi:10.1038/s41537-025-00681-3]

Luis, JG; Adsuara, JS; Andrés, AM; Liria, IC; Iglesias, ML; Maza, MA.

High-fidelity simulation for mental health nurse residents: a mixed-methods study of communication competencies and learning perceptions

Frontiers In Medicine. 2025; 12: [doi:10.3389/fmed.2025.1612777]

El Masri, S; Kowalczyk, OS; Chiu, TH; Criaud, M; Lukito, S; Mazibuko, N; de Pablo, GS; Rodriguez, VP; Makos, O; Lam, SL; Westwood, S; Eaton-Turner, A; Bozhilova, N; Conti, A; Santosh, P; Roessner, V; Kohls, G; Mehta, MA; Rubia, K.

Differential effects of a single dose of Lisdexamfetamine and Guanfacine on cognitive function in children with ADHD

Frontiers in Psychiatry. 2025; 16: [doi:10.3389/fpsyt.2025.1676472]

Howes, OD; Bukala, BR; Chen, EYH; Correll, CU; Hasan, A; Honer, WG; Kane, JM; Leucht, S; Siafis, S; Agid, O; Akena, D; Arango, C; Atwoli, L; Barnes, TRE; Birnbaum, ML; Bitter, I; Breier, A; Buchanan, RW; Citrome, L; Cotter, DR; Crossley, N; Davidson, M; De Bartolomeis, A; Delisi, LE; Dollfus, S; Dursun, SM; Ebdrup, BH; Elkis, H; Emsley, R; Falkai, P; Fernández-Egea, E; Fleischhacker, W; Freudenreich, O; Gadelha, A; Gaebel, W; Graff-Guerrero, A; Gridley, A; Hallak, JEC; Homan, P; Kahn, RS; Kaiser, S; Kapi, M; Kennedy, JL; Kim, E; Kinon, BJ; Kwon, JS; Lawrie, SM; Lee, J; Leweke, FM; Li, T; Libiger, J; Marder, SR; Melle, I; Meltzer, H; Mucci, A; Naber, D; Nakajima, S; Nielsen, J; O'Brien, O; Ojagbemi, A; Omlor, W; Pantelis, C; Peuskens, J; Raedler, TJ; Ran, MS; Marques, TR; Remington, G; Rossell, S; Rubio, JM; Sachs, G; Scott, J; Si, TM; Siskind, D; Siu, CO; Sommer, IE; Suzuki, T; Takeuchi, H; Tandon, R; Taylor, D; Teferra, S; Thomas, N; Tiihonen, J; Uchida, H; Ucok, A; Umbricht, D; Venkatasubramanian, G; Wagner, E; Walters, JTR; Wang, CY; Weiser, M; Wright, C; Yu, X; McCutcheon, RA.

Relapse in Schizophrenia: A Systematic Review of Criteria for Clinical Studies and International Consensus Guidelines to Improve Them

AMERICAN JOURNAL OF PSYCHIATRY. 2025; 182(11): 969-983 Nº de citas: 1 [doi:10.1176/appi.ajp.20241040]

Segura, AG; Verdolini, N; Valli, I; Garcia-Rizo, C; Diaz-Caneja, CM; Vieta, E; Mezquida, G; Lobo, A; Gonzalez-Pinto, A; Andreu-Bernabeu, A; Roldan, A; Martinez-Aran, A; Baeza, I; Mane, A; Labad, J; Müller, DJ; Guasch-Capella, N; Bernardo, M; Mas, S; Bioque, GM; Gonzalez, J; Andrés, P; Cavone, V; Corripio, I; Duque, A; Mar-Barrutia, L; Marin, J; De-la-Camara, C; Vaquero-Puyuelo, D; Rivero, O; Fabra, MJE; Trabsa, A; Legido, T; Forte, MF; Serra-Navarro, M; de la Serna, H; Castro-Fornielles, J; Contreras, F; García-Portilla, MP; González-Blanco, L; Echevarría, RS; Rabadán, AZ; Rodriguez-Jimenez, R; Martínez-Gras, I; Usall, J; Barajas, A; Sarro, S; Pomarol-Clotet, E; Ibañez, A; Cuesta, MJ.

Polygenic risk score of glycemic homeostasis, Type 2 Diabetes Mellitus and glycemic components in first episode psychosis

SCHIZOPHRENIA RESEARCH. 2025; 285: 265-275 [doi:10.1016/j.schres.2025.09.019]

Palagini, L; Arango, C; Bassetti, CLA; Bastien, C; Geoffroy, PA; Elder, G; Ellis, J; Hedner, J; Khullar, A; Nobili, L; Partinen, M; Saletu, M; Vieta, E; Morin, CM; Riemann, D; Strambi, LF; Fiorillo, A.

The need to prioritize "insomnia disorder" in public health agendas: "a wakeup call" position paper from European and Canadian experts in sleep and mental health

SLEEP MEDICINE. 2025; 135: [doi:10.1016/j.sleep.2025.106763]

Bilgrami, ZR; Castro, E; Agurto, C; Liebenthal, E; Ennis, M; Baker, JT; Scott, I; Colton, BL; Cho, KIK; Li, LY; Tamayo, Z; Henecks, M; Eichi, HR; Henry, T; Addington, J; Alameda, LK; Arango, C; Breitborde, NJK; Broome, MR; Cadenhead, KS; Calkins, ME; Chen, EYH; Choi, J; Conus, P; Cornblatt, BA; Ellman, LM; Fusar-Poli, P; Gaspar, PA; Gerber, C; Glenthoj, LB; Horton, LE; Hui, CSY; Kambeitz, J; Kambeitz-Ilankovic, L; Keshavan, MS; Kim, SW; Koutsouleris, N; Kwon, JS; Langbein, K; Mamah, D; Diaz-Caneja, CM; Mathalon, DH; Mittal, VA; Nordentoft, M; Pearlson, GD; Perez, J; Perkins, DO; Powers, AR; Rogers, J; Sabb, FW; Schiffman, J; Shah, JL; Silverstein, SM; Smesny, S; Stone, WS; Yassin, W; Strauss, GP; Thompson, JL; Upthegrove, R; Verma, S; Wang, JJ; Wolf, DH; Mcgorry, PD; Kahn, RS; Kane, JM; Anticevic, A; Bearden, CE; Dwyer, D; Billah, T; Bouix, S; Pasternak, O; Shenton, ME; Woods, SW; Nelson, B; Cecchi, GA; Corcoran, CM; Wolff, PM.

Collecting language, speech acoustics, and facial expression to predict psychosis and other clinical outcomes: strategies from the AMP® SCZ initiative

Schizophrenia. 2025; 11(1): Nº de citas: 1 [doi:10.1038/s41537-025-00669-z]